Fermer le menu


Member of Lyonbiopole


ONCOMECA SAS is a French start-up designing a non-invasive eponym medical device (MD) which provides in vivo diagnosis of skin disorders including early stage 1 melanoma.

It is a class IIb medical device according to the EU regulation 2017/745. Our patented technology lies in the identification of early skin cancers using their mechanical markers combined to their visual characteristics. Our expertise has been miniaturized and automatized to provide an easy-to-use and 88% reliable technology!

It is intended for use by dermatologists and general practitioners and aims at revolutionizing skin cancer diagnosis to hasten patient care.

“At ONCOMECA, we innovate to provide early diagnosis for everybody.”

Julien Chlasta CEO, ONCOMECA


Strategic application domain: Human Medicine

Application market: Oncology

Type of activity: E-Health, Medical device

Technologies: Others

Created on feb. 7th, 2020 - 4 employees



60, avenue Rockefeller 69008 Lyon



Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.

R&D projects